SOD2 and triple-A syndrome: SOD2 mRNA delivery significantly mitigated AAA progression (AD = 0.57 ± 0.02 mm in HA-SOD2 mRNA NP vs AD = 0.79 ± 0.02 mm in HBSS, P < 0.001) (Figure 3C).